Infection as a Trigger for Portal Hypertension.

作者: Christian J. Steib , Julia Schewe , Alexander L. Gerbes

DOI: 10.1159/000375352

关键词: Hepatic stellate cellRifaximinGastroenterologyMedicineCirrhosisImmune systemPortal venous pressurePortal hypertensionKupffer cellInternal medicineSpontaneous bacterial peritonitis

摘要: BACKGROUND Microbial infections are a relevant problem for patients with liver cirrhosis. Different types of bacteria responsible different kinds infections: Escherichia coli and Klebsiella pneumoniae frequently observed in spontaneous bacterial peritonitis or urinary tract infections, Streptococcus Mycoplasma pulmonary infections. Mortality is up to 4-fold higher infected cirrhosis than without Key Messages: Infections due three major reasons: translocation, immune deficiency an increased incidence systemic Nonparenchymal cells like Kupffer cells, sinusoidal endothelial hepatic stellate the first come into contact microbial products when infection translocation occurs. cell (KC) activation by Toll-like receptor (TLR) agonists dysfunction have been shown be important mechanisms increasing portal pressure following intraperitoneal lipopolysaccharide pretreatment cirrhotic rat livers. Reduced intrahepatic vasodilation vasoconstriction pathophysiological pathways. Thromboxane A2 leukotriene (LT) C4/D4 identified as vasoconstrictors. Accordingly, treatment montelukast inhibit cysteinyl-LT1 reduced Clinical studies demonstrated that KCs, estimated amount soluble CD163 blood, correlates risk variceal bleeding. Additionally, intestinal decontamination rifaximin alcohol-associated CONCLUSIONS TLR nonparenchymal pathogens results hypertension. This might explain pathophysiologic correlation between hypertension These findings basis both better stratifying new options, such specific inhibition

参考文章(47)
Christian J. Steib, Alexander L. Gerbes, Signaling Pathways in Liver Diseases Kupffer Cells Springer, Berlin, Heidelberg. pp. 69- 78 ,(2010) , 10.1007/978-3-642-00150-5_4
N. C. Chavez-Tapia, T. Barrientos-Gutierrez, F. Tellez-Avila, K. Soares-Weiser, N. Mendez-Sanchez, C. Gluud, M. Uribe, Meta-analysis: antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding - an updated Cochrane review. Alimentary Pharmacology & Therapeutics. ,vol. 34, pp. 509- 518 ,(2011) , 10.1111/J.1365-2036.2011.04746.X
Jiannis Vlachogiannakos, Nikos Viazis, Panagiota Vasianopoulou, Irene Vafiadis, Dimitrios G Karamanolis, Spiros D Ladas, Long‐term administration of rifaximin improves the prognosis of patients with decompensated alcoholic cirrhosis Journal of Gastroenterology and Hepatology. ,vol. 28, pp. 450- 455 ,(2013) , 10.1111/JGH.12070
M Hennenberg, J Trebicka, C Stark, AZ Kohistani, J Heller, T Sauerbruch, Sorafenib targets dysregulated Rho kinase expression and portal hypertension in rats with secondary biliary cirrhosis British Journal of Pharmacology. ,vol. 157, pp. 258- 270 ,(2009) , 10.1111/J.1476-5381.2009.00158.X
Ming-Chih Hou, Han-Chieh Lin, Tsu-Te Liu, Benjamin Ing-Tieu Kuo, Fa-Yauh Lee, Full-Young Chang, Shou-Dong Lee, Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: A randomized trial Hepatology. ,vol. 39, pp. 746- 753 ,(2004) , 10.1002/HEP.20126
Thomas Reiberger, Arnulf Ferlitsch, Berit A. Payer, Mattias Mandorfer, Birgit B. Heinisch, Hubert Hayden, Frank Lammert, Michael Trauner, Markus Peck-Radosavljevic, Harald Vogelsang, Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis. Journal of Hepatology. ,vol. 58, pp. 911- 921 ,(2013) , 10.1016/J.JHEP.2012.12.011
Qiang Zhu, Li Zou, Kumaravelu Jagavelu, Douglas A. Simonetto, Robert C. Huebert, Zhi-Dong Jiang, Herbert L. DuPont, Vijay H. Shah, Intestinal decontamination inhibits TLR4 dependent fibronectin-mediated cross-talk between stellate cells and endothelial cells in liver fibrosis in mice Journal of Hepatology. ,vol. 56, pp. 893- 899 ,(2012) , 10.1016/J.JHEP.2011.11.013
Mariona Graupera, Joan-Carles Garcıa-Pagán, Juan G Abraldes, Carmen Peralta, Mireia Bragulat, Helena Corominola, Jaume Bosch, Juan Rodés, Cyclooxygenase-derived products modulate the increased intrahepatic resistance of cirrhotic rat livers Hepatology. ,vol. 37, pp. 172- 181 ,(2003) , 10.1053/JHEP.2003.50004
John Goulis, Anastasios Armonis, David Patch, Caroline Sabin, Lynda Greenslade, Andrew K. Burroughs, Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage Hepatology. ,vol. 27, pp. 1207- 1212 ,(1998) , 10.1002/HEP.510270504
Christian Mortensen, Stine Karlsen, Henning Grønbaek, Dennis T. Nielsen, Susanne Frevert, Jens O. Clemmesen, Søren Møller, Jørgen S. Jensen, Flemming Bendtsen, No difference in portal and hepatic venous bacterial DNA in patients with cirrhosis undergoing transjugular intrahepatic portosystemic shunt insertion. Liver International. ,vol. 33, pp. 1309- 1315 ,(2013) , 10.1111/LIV.12205